对糖尿病相关生活质量的概念分析
Anggi Lukman Wicaksana1,2, Nuzul Sri Hertanti3
1Department of Medical Surgical Nursing, Universitas Gadjah Mada, Ismangoen Bd. 2F Jl. Famako, Sekip Utara, Kompleks FKKMK UGM Yogyakarta, 51482, Yogyakarta, Indonesia. anggi.l.wicaksana@ugm.ac.id.
Health and quality of life outcomes
|March 25, 2025
概括
这项研究澄清了糖尿病成年人的糖尿病相关生活质量 (DRQoL). 关键属性包括一般健康,满意度,影响力和自我管理,改善护理认可.
科学领域:
- 健康科学 卫生科学 卫生科学
- 医学研究 医学研究
- 糖尿病 护理 糖尿病 护理
背景情况:
- 生活质量 (QoL) 是糖尿病预后的一个关键指标.
- 与糖尿病相关的 QoL (DRQoL) 的概念需要澄清.
研究的目的:
- 定义和澄清DRQoL在糖尿病成年人的核心知识.
主要方法:
- 使用沃克和阿万特的框架进行概念分析.
- 在三个数据库中进行系统的文献搜索 (2002-2022年).
- 对183篇关于糖尿病成年人DRQoL的英语同行评审文章的分析.
主要成果:
- 确定了四个关键的DRQoL组件:一般健康,与糖尿病相关的满意度,糖尿病影响和自我管理.
- 分类先例 (积极,中性,负面) 和后果 (死亡风险,健康,满意度,住院,返回工作).
- 发现了32个DRQoL测量工具,包括疾病特定和一般的QoL尺度.
结论:
- 提供了成年糖尿病患者DRQoL的定义和框架.
- 突出DRQoL属性:一般健康,满意度,影响力和自我管理.
- 强调了解DRQoL可以提高护理质量,并识别患者的需求.
更多相关视频
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
494
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
494
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
Pathophysiology of Diabetes
833
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
833
Insulin: Dosing Regimen and Adverse Effects
132
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
132


